CD
De Ramon Ortiz, Carmen Julia
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Azacitidine-induced remission enables allogeneic transplantation in TET2/BCOR-mutant relapsed extranodal natural killer/T-cell lymphoma : a case report | Haematologica |  | 2026 | 9 | 36 | ||
| Updated recommendations for diagnosis and treatment of multiple myeloma in Switzerland | Swiss medical weekly | | 2025 | 1 | 2 | ||
| Updated recommendations for the treatment of light-chain amyloidosis from the Swiss Amyloidosis Network | Swiss medical weekly | | 2025 | 1 | 0 | ||
| Anti-BCMA and GPRC5D bispecific antibodies in relapsed/refractory primary plasma cell leukemia : a case report | Frontiers in immunology | | 2024 | 42 | 150 | ||
| Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation : a case report | Frontiers in immunology | | 2024 | 61 | 158 | ||
| How to integrate CD19 specific chimeric antigen receptor T cells with other CD19 targeting agents in diffuse large B-cell lymphoma? | Hematological oncology | | 2024 | 115 | 168 | ||
| Low plasma levels of hyaluronic acid might rule out sinusoidal obstruction syndrome after hematopoietic stem cell transplantation | Disease markers | | 2023 | 85 | 181 | ||
| Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation : A Retrospective Study | Transplantation and cellular therapy | | 2022 | 139 | 353 | ||
| The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft | Bone marrow transplantation |  | 2021 | 352 | 0 | ||
| Le myélome multiple chez la personne âgée : impact d'une évaluation gériatrique | Revue médicale suisse | | 2019 | 708 | 503 |
